Boston, MA – According to filings with the U.S. Securities and Exchange Commission, Emulate Inc. is raising $50,000,000.00 in a new round of investment. Sources indicate as part of senior management Chief Executive Officer, James Coon played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Emulate Inc.

At Emulate we’ve created a new living system that emulates human biology – to understand how diseases, medicines, chemicals, and foods affect human health. Our Human Emulation System sets a new standard for recreating true-to-life human biology and is being used to advance product innovation, design, and safety across a range of applications, including drug development, agriculture, cosmetics, food, and chemical-based consumer products.

To learn more about Emulate Inc., visit http://www.emulatebio.com/

Contact:
James Coon, Chief Executive Officer
617-704-9222
james.coon@emulatebio.com
https://www.linkedin.com/in/james-coon-b509a93/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved